Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT02177292 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

High-Dose Lymph Node Intensity Modulated Radiation Therapy and Hypofractionated Prostate (SIB)

Study acronym: SIB
StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Completion pushed from Aug 17, 2026 to Aug 17, 2027 Eligibility criteria expanded, about 12 words · Site details revised · Publications: details revised at 1 of 1 entry · 1 more Show 4 more changesShow less
    • Eligibility criteria expanded, about 12 words
    • Site details revised
    • Publications: details revised at 1 of 1 entry
    • Study description expanded, about 3 words
  2. Primary completion date changed from estimate of Apr 1, 2026 to Mar 2, 2026 Completion date: Jun 21, 2030 to Aug 17, 2026v19 Show 1 more changeShow less
    • Completion date: Jun 21, 2030 to Aug 17, 2026
  3. Primary completion date: Jun 22, 2026 to Apr 1, 2026v18
  4. Primary completion date: Dec 2026 to Jun 22, 2026 Completion date: Dec 2026 to Jun 21, 2030v17 Show 1 more changeShow less
    • Completion date: Dec 2026 to Jun 21, 2030
  5. Study site revisedv16 See this version in full on ClinicalTrials.gov ↗
Show 14 earlier versionsHide 14 earlier versions
  1. Primary completion date: Dec 2023 to Dec 2026 Primary endpoints: 1 to 13 · Secondary endpoints shortened, about 26 wordsv15 Show 2 more changesShow less
    • Primary endpoints: 1 to 13
    • Secondary endpoints shortened, about 26 words

    See this version in full on ClinicalTrials.gov ↗

  2. Trial status: Recruiting to Active, Not Recruiting Enrollment target: estimated 30 to confirmed 80 · Site details revisedv14 Show 2 more changesShow less
    • Enrollment target: estimated 30 to confirmed 80
    • Site details revised
  3. Re-verified, no change to tracked fieldsv13
  4. Primary completion date: Dec 2020 to Dec 2023 Primary endpoint revised · Completion date: Dec 2060 to Dec 2026 · Secondary endpoints: 2 to 13 · 1 morev12 Show 4 more changesShow less
    • Primary endpoint revised
    • Completion date: Dec 2060 to Dec 2026
    • Secondary endpoints: 2 to 13
    • Eligibility criteria shortened, about 4 words

    See this version in full on ClinicalTrials.gov ↗

  5. Phase: Phase 2 to Not applicable Start date: Jun 2010 to Jun 23, 2010v11 Show 1 more changeShow less
    • Start date: Jun 2010 to Jun 23, 2010
  6. 3 versions Re-verified since Apr 6, 2018, no change to tracked fieldsv8-v10
  7. Trial status: Active, Not Recruiting to Recruiting Site details revisedv7 Show 1 more changeShow less
    • Site details revised
  8. Primary completion date: Dec 2016 to Dec 2020v6
  9. Re-verified, no change to tracked fieldsv5
  10. Primary completion date: Dec 2015 to Dec 2016v4
  11. Trial status: Recruiting to Active, Not Recruiting Site details revisedv3 Show 1 more changeShow less
    • Site details revised
  12. Re-verified, no change to tracked fieldsv2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this study is to find out the effects (good and bad) of using newer technologies that allow very precise delivery of radiation. These newer technologies are Intensity Modulated Radiation Therapy (IMRT) and Image Guided Radiation Therapy (IGRT).
Trial Details
NCT Number NCT02177292
Lead Sponsor Medical College of Wisconsin
Conditions Prostate Cancer
Enrollment 80 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov